000 01421 a2200433 4500
005 20250515062758.0
264 0 _c20070423
008 200704s 0 0 eng d
022 _a0004-4172
024 7 _a10.1055/s-0031-1296591
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrennscheidt, Ulrich
245 0 0 _aPharmacokinetics of tilidine and naloxone in patients with severe hepatic impairment.
_h[electronic resource]
260 _bArzneimittel-Forschung
_c2007
300 _a106-11 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnalgesics, Opioid
_xpharmacokinetics
650 0 4 _aArea Under Curve
650 0 4 _aBiotransformation
650 0 4 _aChromatography, Gas
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aLidocaine
_xanalogs & derivatives
650 0 4 _aLiver Cirrhosis, Alcoholic
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNaloxone
_xpharmacokinetics
650 0 4 _aNarcotic Antagonists
_xpharmacokinetics
650 0 4 _aTilidine
_xpharmacokinetics
700 1 _aBrunnmüller, Ulrike
700 1 _aProppe, Dietfried
700 1 _aThomann, Peter
700 1 _aSeiler, Klaus-Ulrich
773 0 _tArzneimittel-Forschung
_gvol. 57
_gno. 2
_gp. 106-11
856 4 0 _uhttps://doi.org/10.1055/s-0031-1296591
_zAvailable from publisher's website
999 _c16950425
_d16950425